Skip to content

Hemostasis Using Surgicel in Pediatric Tonsillectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03984851
Enrollment
203
Registered
2019-06-13
Start date
2016-01-01
Completion date
2019-01-01
Last updated
2019-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Blood Loss, Tonsil; Injury

Keywords

tonsillectomy, primary hemostasis tonsillectomy, surgicel

Brief summary

Tonsillectomy is one of the commonest procedures performed in otolaryngology and one of its major complications is post-tonsillectomy bleeding. The goal of this study was to assess the effectiveness of Surgicel without bipolar cautery in achieving primary hemostasis in tonsillectomy. The patient that were enrolled in this retrospective study were patients who underwent tonsillectomy and achieved hemostasis either by Surgicel (group A) or bipolar cautery (group B). Our results showed that there was no statistical significant difference between the two techniques in terms of post-operative bleeding events.

Detailed description

Tonsillectomy is one of the commonest procedures performed in otolaryngology and one of its major complications is post-tonsillectomy bleeding. The goal of this study was to assess the effectiveness of Surgicel without bipolar cautery in achieving primary hemostasis in tonsillectomy. The study was a retrospective cohort in three tertiary care centers in xxxx, from January 2016 to August 2018. All patients underwent at least tonsillectomy, with a proportion undergoing additional adenoidectomy, myringotomy, or tube insertion as indicated, were enrolled in the study. Patients were stratified to 2 groups according to the surgeons preference for the hemostasis technique, one was subjected to cold dissection tonsillectomy and achieved hemostasis via the application of Surgicel to the surgical site, and the other underwent cold dissection tonsillectomy and attained hemostasis through bipolar cautery.

Interventions

None listed

Sponsors

Dr. Abdul Mohsen Ibrahim Al-Turki Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* Patients under age of 12, diagnosed with recurrent tonsillitis or OSA and are candidates for tonsillectomy * patients must have went tonsillectomy

Exclusion criteria

* age more than 12

Design outcomes

Primary

MeasureTime frameDescription
Primary Post-operative tonsillectomy bleeding24 hours post-opBleeding due to the surgical procedure within 24 hours from the surgery
Secondary Post-operative Tonsillectomy bleedingafter 24 hoursBleeding due to the surgical procedure after 24 hours from the surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026